GLP-3 RT

GLP-3 RT 

Tri-Agonist Peptide for In Vitro Research

GLP-3 RT (Retatrutide) is a synthetic tri-agonist peptide that simultaneously activates the glucagon-like peptide-1 (GLP-1) receptor, glucose-dependent insulinotropic polypeptide (GIP) receptor, and glucagon receptor. Structurally, GLP-3 R is engineered to maintain high receptor binding affinity across all three targets, enabling the study of synergistic receptor signaling pathways.

The molecule consists of 94 amino acids, modified for increased stability and bioactivity under in vitro conditions. Its sequence incorporates targeted amino acid substitutions and a lipidation motif to enhance half-life and receptor co-activation dynamics.

For In Vitro Research Use Only. Not for Human or Veterinary Application.

Specifications:

Form: Lyophilized Powder

Molecular Formula: C₃₁₆H₄₈₁F₃N₉₄O₁₀₁

Molecular Weight: ~6758.22 g/mol

Purity: >99.9% (HPLC verified)

Storage: -20°C, protect from light and moisture

Intended Use:

This peptide is intended for in vitro research only by qualified professionals. It is not for human or veterinary use, and must not be used in food, drugs, diagnostics, or cosmetics.

Disclaimer:

All product photos are purely informational. Final packaging, labelling, and appearance may differ from the images displayed.

This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must follow institutional and regulatory guidelines.

Terms of Sale:

By purchasing from Cernum Biosciences, the buyer expressly certifies that they are a qualified and licensed researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance. The buyer acknowledges that all products are strictly for laboratory research use only, not for human or veterinary use, and assumes full legal responsibility for proper handling, storage, use, and compliance with all applicable federal, state, and local laws and regulations.